Related Experiment Video
Updated: Jun 20, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated
Ha Won Kim1, Husnain K Haider, Shujia Jiang
1Department of Pathology, University of Cincinnati, Cincinnati, Ohio 45267, USA.
Abstract:
MicroRNAs (miRs) participate in most cellular functions by posttranscriptional regulation of gene expression albeit with little information regarding their role in ischemic preconditioning (IP) of stem cells. We report that IP of bone marrow-derived mesenchymal stem cells (MSCs) with two cycles of 30-min ischemia/reoxygenation (I/R) supported their survival under subsequent longer exposure to anoxia and following engraftment in the infarcted heart. IP significantly reduced apoptosis in MSCs through activation of Akt (Ser(473)) and ERK1/2 (Thr(202)/Tyr(204)) and nuclear translocation of hypoxia-inducible factor-1alpha (HIF-1alpha). We observed concomitant induction of miR-210 in the preconditioned MSCs ((PC)MSCs). Inhibition of HIF-1alpha or of miR-210 abrogated the cytoprotective effects of preconditioning. Extrapolation of these data to in vivo studies in a rat model of acute myocardial infarction predominantly improved stem cell survival after engraftment with a role for miR-210. Notably, multiple I/R cycles more effectively regulated the miR-210 and hence promoted MSC survival compared with single-cycle hypoxia of an equal duration. Real time PCR array for rat apoptotic genes, computational target gene analyses, and luciferase reporter assay identified FLICE-associated huge protein (FLASH)/caspase-8-associated protein-2 (Casp8ap2) in (PC)MSCs as the target gene of miR-210. Induction of FLASH/CASP8AP2 in miR-210 knocked-down (PC)MSCs resulted in increased cell apoptosis. Taken together, these data demonstrated that cytoprotection afforded by IP was regulated by miR-210 induction via FLASH/Casp8ap2 suppression. These results highlighted that IP by multiple short episodes of I/R is a novel strategy to promote stem cell survival.
Insights
Ischemic preconditioning (IP) enhances mesenchymal stem cell (MSC) survival by activating survival pathways and inducing miR-210, which targets FLASH/Casp8ap2. This strategy improves stem cell survival in myocardial infarction models.
Area of Science:
- Stem cell biology
- Molecular biology
- Cardiovascular research
Background:
- MicroRNAs regulate gene expression, but their role in stem cell ischemic preconditioning is unclear.
- Ischemic preconditioning (IP) aims to protect cells from ischemic injury.
Purpose of the Study:
- To investigate the role of microRNAs, specifically miR-210, in the ischemic preconditioning of mesenchymal stem cells (MSCs).
- To elucidate the protective mechanisms of IP in MSCs and their efficacy in a myocardial infarction model.
Main Methods:
- MSCs were subjected to ischemic preconditioning (IP) using cycles of ischemia/reoxygenation (I/R).
- Apoptosis, cell signaling pathways (Akt, ERK1/2), and hypoxia-inducible factor-1alpha (HIF-1alpha) were assessed.
- miR-210 expression and its target gene, FLASH/Casp8ap2, were analyzed.
- In vivo studies utilized a rat model of acute myocardial infarction.
Main Results:
- IP significantly enhanced MSC survival under anoxia and improved engraftment in infarcted hearts.
- IP activated Akt, ERK1/2, and HIF-1alpha, leading to miR-210 induction.
- Inhibition of HIF-1alpha or miR-210 abolished the protective effects of IP.
- miR-210 directly targeted FLASH/Casp8ap2, suppressing its expression and reducing apoptosis.
- Multiple short I/R cycles were more effective than single prolonged hypoxia.
Conclusions:
- Ischemic preconditioning protects MSCs via miR-210 induction, which suppresses FLASH/Casp8ap2.
- This miR-210-mediated pathway is crucial for stem cell survival under ischemic stress.
- IP using multiple short I/R episodes is a promising strategy to enhance stem cell therapy for myocardial infarction.
More Related Videos
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
08:03Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022